JP2950348B2 - Fat emulsion and method for producing the same - Google Patents
Fat emulsion and method for producing the sameInfo
- Publication number
- JP2950348B2 JP2950348B2 JP3222031A JP22203191A JP2950348B2 JP 2950348 B2 JP2950348 B2 JP 2950348B2 JP 3222031 A JP3222031 A JP 3222031A JP 22203191 A JP22203191 A JP 22203191A JP 2950348 B2 JP2950348 B2 JP 2950348B2
- Authority
- JP
- Japan
- Prior art keywords
- fat
- fat emulsion
- emulsion
- oil
- phospholipids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002960 lipid emulsion Substances 0.000 title claims description 78
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- 239000002245 particle Substances 0.000 claims description 33
- 239000003995 emulsifying agent Substances 0.000 claims description 30
- 239000003925 fat Substances 0.000 claims description 28
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 24
- 239000008103 glucose Substances 0.000 claims description 24
- 239000000839 emulsion Substances 0.000 claims description 22
- 239000003921 oil Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 13
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 150000003904 phospholipids Chemical class 0.000 claims description 9
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 239000008344 egg yolk phospholipid Substances 0.000 claims description 8
- 229940068998 egg yolk phospholipid Drugs 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- 239000005715 Fructose Substances 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 239000008347 soybean phospholipid Substances 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 3
- 230000009469 supplementation Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 2
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 40
- 235000011187 glycerol Nutrition 0.000 description 20
- 235000019197 fats Nutrition 0.000 description 19
- 238000001802 infusion Methods 0.000 description 18
- 238000004659 sterilization and disinfection Methods 0.000 description 15
- 230000001954 sterilising effect Effects 0.000 description 14
- 150000001720 carbohydrates Chemical class 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 238000004945 emulsification Methods 0.000 description 8
- 238000005191 phase separation Methods 0.000 description 7
- 235000010356 sorbitol Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000003549 soybean oil Substances 0.000 description 5
- 235000012424 soybean oil Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 229910001873 dinitrogen Inorganic materials 0.000 description 4
- -1 for example Substances 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 230000005484 gravity Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- BTLPCOOVNVTENY-UHFFFAOYSA-N 8L8 Natural products CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC BTLPCOOVNVTENY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- OCJAHRQBZPOWQF-LTXDKZCQSA-N 1,3-di(decanoyloxy)propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC OCJAHRQBZPOWQF-LTXDKZCQSA-N 0.000 description 1
- BTLPCOOVNVTENY-NFYLBXPESA-N 1,3-di(octanoyloxy)propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC BTLPCOOVNVTENY-NFYLBXPESA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Substances OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000021542 oral nutrition Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940035024 thioglycerol Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Landscapes
- Edible Oils And Fats (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は脂肪乳剤及びその製造法
に関し、より詳細には安定性を改良した栄養補給用脂肪
乳剤及びその製造法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a fat emulsion and a method for producing the same, and more particularly to a fat emulsion for nutritional supplement with improved stability and a method for producing the same.
【0002】[0002]
【従来の技術】従来、患者の生命の維持において、経口
栄養、経管栄養が不可能であったり、あるいは不十分な
状態であったり、又はそれらが可能ではあっても患者の
消化吸収機能が著しく不良であったり、更には食物が消
化管を通過するのが原疾患の悪化につながるような病態
の場合には、栄養補給のために、経静脈的に輸液の投与
が行われている。このような輸液製剤としては、還元糖
等の糖類を含有する糖輸液、必須アミノ酸等を含有する
アミノ酸輸液、ミネラル類を含有する電解質輸液、植物
油乳剤等を含有する脂肪乳剤、混合ビタミン剤などが市
販されており、これらの輸液製剤を患者の症状などに合
わせて、使用時に適宜混合して用いられている。2. Description of the Related Art Conventionally, in the maintenance of a patient's life, oral nutrition and tube feeding have been impossible or inadequate, or even if they are possible, the digestive and absorptive function of the patient is reduced. In cases where the condition is extremely poor or the passage of food through the digestive tract leads to an exacerbation of the underlying disease, an infusion is administered intravenously for nutritional supplementation. Examples of such infusion preparations include sugar infusions containing saccharides such as reducing sugars, amino acid infusions containing essential amino acids and the like, electrolyte infusions containing minerals, fat emulsions containing vegetable oil emulsions and the like, and mixed vitamin preparations. They are commercially available, and these infusion preparations are appropriately mixed and used at the time of use according to the symptoms of the patient.
【0003】[0003]
【発明が解決しようとする課題】上記の各種輸液製剤の
うち、脂肪乳剤は、通常、植物油等の油脂を乳化剤を用
いて水に分散させて水中油型乳剤とすることにより調製
されるが、脂肪乳剤は不安定で、加熱滅菌時や保存中に
経時的に油脂粒子の粗大化を生じ易い。また、上述のよ
うに、各種輸液剤は使用時に混合して用いられるが、輸
液製剤の使用時における混合は作業従事者にとって煩雑
な操作であり、なによりも混合時に菌汚染の問題があ
る。このような問題から、脂肪乳剤と他の輸液製剤とを
事前に混合した輸液製剤が検討されているが、脂肪乳剤
は不安定であり、混合により乳剤の崩壊、油脂粒子の粗
大化、相分離等を生じ易く、実用上種々の問題がある。
特に、脂肪乳剤に糖類を配合した製剤においては、両液
の比重の相違から相分離が起り易い。上記のように、脂
肪乳剤は安定性が劣り、また他の輸液剤との混合適性に
欠ける。特に脂肪乳剤に糖類を配合した輸液製剤におい
ては、脂肪乳剤の相分離が生じ易く、長期にわたり安定
な製剤を得られないという問題がある。そのため、安定
性に優れた脂肪乳剤が切望されている。本発明者らは上
記事情に鑑み、脂肪乳剤の安定化について鋭意検討した
結果、脂肪乳剤の平均粒子径を小さくすることにより脂
肪乳剤の安定性が著しく向上し、相分離などが起こりに
くくなることを見出した。本発明は上記の知見に基づい
てなされたものである。脂肪乳剤の平均粒子径を小さく
するには、通常、乳化剤の使用量を多くすることが行わ
れるが、リン脂質等の乳化剤の使用量を多くすると、脂
肪乳剤中の遊離脂肪酸含量が増大する。遊離脂肪酸は、
脂肪乳剤の毒性の原因となるおそれがあるので、脂肪乳
剤中の遊離脂肪酸含量は極力低下させる必要があり、そ
のため多量の乳化剤を使用することはできない。本発明
は上記従来技術の問題点を解消するために創案されたも
ので、本発明は安定性に優れた脂肪乳剤及びその製造法
を提供することを目的とする。Of the various infusion preparations described above, the fat emulsion is usually prepared by dispersing a fat or oil such as a vegetable oil in water using an emulsifier to form an oil-in-water emulsion. Fat emulsions are unstable and tend to cause coarsening of fat particles over time during heat sterilization or storage. In addition, as described above, various infusions are mixed at the time of use, but mixing at the time of use of the infusion preparation is a complicated operation for workers, and above all, there is a problem of bacterial contamination during mixing. In view of such problems, infusion preparations in which a fat emulsion and another infusion preparation are mixed in advance have been studied.However, the fat emulsion is unstable, and the emulsion disintegrates, the fat and oil particles become coarse, and phase separation occurs due to mixing. Etc. are likely to occur, and there are various practical problems.
In particular, in a formulation in which a saccharide is blended with a fat emulsion, phase separation is likely to occur due to the difference in specific gravity between the two solutions. As mentioned above, fat emulsions have poor stability and lack compatibility with other infusions. In particular, in an infusion preparation in which a saccharide is mixed with a fat emulsion, phase separation of the fat emulsion easily occurs, and there is a problem that a stable preparation cannot be obtained for a long period of time. Therefore, a fat emulsion having excellent stability has been desired. In view of the above circumstances, the present inventors have conducted intensive studies on stabilization of a fat emulsion.As a result, by reducing the average particle size of the fat emulsion, the stability of the fat emulsion is significantly improved, and phase separation and the like are less likely to occur. Was found. The present invention has been made based on the above findings. In order to reduce the average particle size of the fat emulsion, the amount of the emulsifier used is usually increased. However, when the amount of the emulsifier such as phospholipid is increased, the free fatty acid content in the fat emulsion increases. Free fatty acids are
Since it may cause toxicity of the fat emulsion, the free fatty acid content in the fat emulsion must be reduced as much as possible, so that a large amount of emulsifier cannot be used. The present invention has been made to solve the above-mentioned problems of the prior art, and an object of the present invention is to provide a fat emulsion having excellent stability and a method for producing the same.
【0004】[0004]
【課題を解決するための手段】上記の課題を解決するた
め、本発明者らは平均粒子径の小さい栄養補給用脂肪乳
剤を得るべく鋭意検討した結果、脂肪乳剤の調製時にグ
リセリン及び/又はブドウ糖を共存させると脂肪乳剤の
平均粒子径を小さくすることができ、それにより脂肪乳
剤の安定性が著しく向上し、相分離などが起こりにくく
なることを見出して本発明を完成した。即ち、本発明の
脂肪乳剤は、油脂を乳化剤を用いて乳化させた栄養補給
用脂肪乳剤であって、乳化剤含量が0.01〜5.0W/V%であ
り、脂肪乳剤の平均粒子径が0.17μm以下のものであ
る。また、本発明の脂肪乳剤の製造方法は、上記脂肪乳
剤の製造法であり、油脂を、グリセリン及びブドウ糖か
ら選ばれた1種又は2種とともに乳化剤を用いて乳化
し、平均粒子径が0.17μm以下の脂肪乳剤を得るもので
ある。Means for Solving the Problems In order to solve the above problems, the present inventors have intensively studied to obtain a nutritional supplement fat emulsion having a small average particle size. As a result, glycerin and / or glucose were prepared during the preparation of the fat emulsion. The present invention was found to be able to reduce the average particle size of the fat emulsion when coexisting, thereby significantly improving the stability of the fat emulsion and making it difficult to cause phase separation and the like. That is, the fat emulsion of the present invention is a nutritional supplement fat emulsion obtained by emulsifying fats and oils with an emulsifier, the emulsifier content is 0.01 to 5.0 W / V%, and the average particle size of the fat emulsion is 0.17 μm or less. belongs to. The method for producing a fat emulsion of the present invention is a method for producing the above-mentioned fat emulsion, and emulsifies fats and oils with an emulsifier together with one or two kinds selected from glycerin and glucose, and has an average particle diameter of 0.17 μm. The following fat emulsion is obtained.
【0005】本発明は上記の構成からなり、本発明の脂
肪乳剤及び本発明の製造法により得られる脂肪乳剤は、
油脂を乳化剤を用いて水に分散させて調製された水中油
型乳剤であって、平均粒子径が0.17μm以下の栄養
補給用脂肪乳剤である。上記の油脂としては食用油であ
ればいずれの油脂も使用でき、例えば、植物油(例え
ば、大豆油、綿実油、サフラワー油、トウモロコシ油、
ヤシ油、シソ油、エゴマ油等)、魚油(例えば、タラ肝
油等)、中鎖脂肪酸トリグリセリド[例えば、パナセー
ト(商品名)、ODO(商品名)等]及び化学合成トリ
グリセリド類[例えば、2−リノレオイル−1,3−ジ
オクタノイルグリセロール(8L8)、2−リノレオイ
ル−1,3−ジデカノイルグリセロール(10L10)
等のChemically defined trig
lycerides]から選ばれた1種又は2種以上の
油脂が好適に用いられる。また、乳化剤としてはリン脂
質が使用され、リン脂質としては例えば、卵黄リン脂
質、水素添加卵黄リン脂質、大豆リン脂質、水素添加大
豆リン脂質などが例示され、これらから選ばれた1種又
は2種以上の乳化剤が好適に用いられる。特に好ましく
は、油脂として大豆油、乳化剤として卵黄リン脂質を用
いた脂肪乳剤が挙げられる。The present invention has the above-mentioned constitution, and the fat emulsion of the present invention and the fat emulsion obtained by the production method of the present invention are:
An oil-in-water emulsion prepared by dispersing fats and oils in water using an emulsifier, and a nutritional supplement fat emulsion having an average particle size of 0.17 μm or less. As the above fats and oils, any fats and oils can be used as long as they are edible oils, for example, vegetable oils (for example, soybean oil, cottonseed oil, safflower oil, corn oil,
Palm oil, perilla oil, perilla oil, etc.), fish oil (eg, cod liver oil, etc.), medium-chain fatty acid triglycerides [eg, panassate (trade name), ODO (trade name), etc.] and chemically synthesized triglycerides [eg, 2- Linoleoyl-1,3-dioctanoyl glycerol (8L8), 2-linoleoyl-1,3-didecanoyl glycerol (10L10)
Chemically defined trig
lycerides] is preferably used. Phosphorus fat is used as an emulsifier.
Quality is used, and as the phospholipid, for example,
Quality, hydrogenated egg yolk phospholipid, soybean phospholipid, hydrogenated large
Bean phospholipids are exemplified, and one or more emulsifiers selected from these are preferably used. Particularly preferred is a fat emulsion using soybean oil as an oil and fat and egg yolk phospholipid as an emulsifier.
【0006】本発明の脂肪乳剤は平均粒子径が0.17μm
以下、好ましくは0.15μm以下であり、従来の脂肪乳剤
の平均粒子径0.2〜0.3μmに比べて微粒子化されている
ので高い安定性を有し、特に脂肪乳剤に糖類を配合した
輸液製剤においては、比重の相違による相分離を抑制で
きる。The fat emulsion of the present invention has an average particle size of 0.17 μm
It is preferably 0.15 μm or less, and has high stability because it is finer than the conventional fat emulsion having an average particle diameter of 0.2 to 0.3 μm. In addition, phase separation due to a difference in specific gravity can be suppressed.
【0007】本発明の脂肪乳剤の製造法は上記の特性を
有する脂肪乳剤の製造法であり、脂肪乳剤の調製時にグ
リセリン及びブドウ糖から選ばれた1種又は2種を添加
して乳化し、平均粒子径が0.17μm以下、好ましくは0.1
5μm以下である脂肪乳剤を調製するものである。従来か
ら脂肪乳剤の調製には、水に油脂及び乳化剤を加えた
後、撹拌して粗乳化液を調製し、次いで粗乳化液を高圧
乳化法等により乳化する方法が用いられているが、この
方法では通常、平均粒子径が0.2〜0.3μmの脂肪乳剤が
得られる。平均粒子径を更に小さくするには、乳化剤を
多量に使用すると共により過酷な条件(例えば、乳化機
通過回数を増やすと共に高圧で乳化する)で乳化させる
必要がある。しかし、乳化剤を多量に使用し過酷な条件
で乳化すると、脂肪乳剤中の遊離脂肪酸含量が増加し、
毒性の問題を生ずるので、栄養補給用脂肪乳剤として用
いることはできない。このような問題から、栄養補給用
脂肪乳剤の平均粒子径を小さくすることは困難であっ
た。しかしながら、発明者らはグリセリン及びブドウ糖
に微粒子化を促進する特異的な作用があることを見出し
たもので、本発明の製造法によれば平均粒子径が0.17μ
m以下である脂肪乳剤を容易に調製することができる。
本発明の製造法は、乳剤の調製時にグリセリン及びブド
ウ糖から選ばれた1種又は2種を添加する限り、種々の
態様で実施することができ、その一例を挙げると、水に
油脂及び乳化剤を加えると共にグリセリン及びブドウ糖
から選ばれた1種又は2種を加えた後、撹拌して粗乳化
液を調製し、次いで粗乳化液を高圧乳化法等の慣用の方
法により乳化することにより脂肪乳剤を調製することが
できる。上記の乳化を高圧乳化法で行なう場合、例え
ば、マントンゴーリンホモジナイザー等の乳化機を用
い、粗乳化液を20〜700Kg/cm2程度の条件下、5〜50回程
度、好ましくは10〜25回程度通過させることにより行わ
れる。なお、この方法において、グリセリン及び/又は
ブドウ糖は乳化する際に存在すればよく、例えば、油脂
と乳化剤とで調製した粗乳化液にグリセリン及び/又は
ブドウ糖を添加して乳化を行なってもよい。なお、得ら
れた乳剤の平均粒子径の測定は、光散乱法などの慣用の
測定法を用いることにより行なうことができる。The method for producing a fat emulsion according to the present invention is a method for producing a fat emulsion having the above-mentioned properties. One or two kinds selected from glycerin and glucose are added during the preparation of the fat emulsion, and the emulsion is emulsified. Particle size is 0.17μm or less, preferably 0.1
A fat emulsion having a size of 5 μm or less is prepared. Conventionally, fat emulsions have been prepared by adding oils and fats and an emulsifier to water, stirring to prepare a coarse emulsion, and then emulsifying the coarse emulsion by a high-pressure emulsification method. In the method, a fat emulsion having an average particle size of 0.2 to 0.3 μm is usually obtained. In order to further reduce the average particle size, it is necessary to use a large amount of an emulsifier and emulsify it under more severe conditions (for example, increase the number of times of passing through an emulsifier and emulsify at a high pressure). However, when emulsifying under severe conditions using a large amount of emulsifier, the free fatty acid content in the fat emulsion increases,
It cannot be used as a nutritional fat emulsion because of toxicity problems. Due to such problems, it has been difficult to reduce the average particle size of the fat emulsion for nutritional supplement. However, the inventors have found that glycerin and glucose have a specific action of promoting micronization, and according to the production method of the present invention, the average particle diameter is 0.17 μm.
m or less can be easily prepared.
The production method of the present invention can be carried out in various modes as long as one or two kinds selected from glycerin and glucose are added at the time of preparing an emulsion, and for example, an oil and fat and an emulsifier are added to water. After the addition, one or two selected from glycerin and glucose are added, and the mixture is stirred to prepare a crude emulsion, and then the crude emulsion is emulsified by a conventional method such as a high-pressure emulsification method to form a fat emulsion. Can be prepared. When the above emulsification is carried out by a high-pressure emulsification method, for example, using an emulsifier such as a Manton-Gaulin homogenizer, the coarse emulsion is subjected to about 5 to 50 times, preferably about 10 to 25 times under conditions of about 20 to 700 kg / cm2. This is done by passing through to some extent. In this method, glycerin and / or glucose may be present at the time of emulsification. For example, glycerin and / or glucose may be added to a coarse emulsion prepared from fats and oils and an emulsifier to perform emulsification. The average particle size of the obtained emulsion can be measured by using a conventional measuring method such as a light scattering method.
【0008】上記の製造法において、油脂、乳化剤並び
にグリセリン及び/又はブドウ糖の使用量としては、得
られた脂肪乳剤が、油脂0.1〜30W/V%(以下、特別な明示
のない限り、%はW/V%を示す)程度、好ましくは2〜10%程
度、乳化剤0.01〜5.0%、好ましくは0.05〜3%程度、グリ
セリン及び/又はブドウ糖30〜70%程度、好ましくは40
〜60%程度、及び全量を100とするに必要な水とから構成
されるように調整して使用される。In the above-mentioned production method, the amount of the fats and oils, emulsifier, glycerin and / or glucose used is such that the fat emulsion obtained is 0.1 to 30 W / V% of fats and oils (hereinafter, unless otherwise specified,% is W / V%), preferably about 2 to 10%, emulsifier 0.01 to 5.0%, preferably about 0.05 to 3%, glycerin and / or glucose about 30 to 70%, preferably about 40
It is adjusted so that it is composed of about 60% and water necessary to make the total amount 100.
【0009】かくして得られた本発明の脂肪乳剤は、水
を用いて希釈したり、糖類を添加して糖濃度を調整する
等、所望に応じて適宜な形態としてもよい。上記の糖類
としては、輸液に用いられる糖類であれば種々の糖類を
用いることができるが、例えば、ブドウ糖、果糖、マル
トース、ソルビトール、キシリトール、グリセリン等が
挙げられる。糖類の濃度が調整された脂肪乳剤の組成の
好適な例としては、油脂0.1〜30%、好ましくは1〜20%、
より好ましくは2〜10%、乳化剤0.01〜5.0%、好ましくは
0.05〜3%、より好ましくは0.1〜1%、ブドウ糖、果糖、
マルトース、ソルビトール、キシリトール及びグリセリ
ンから選ばれた1種又は2種以上の糖類5〜60%、好まし
くは10〜40%、より好ましくは15〜30%、及び全量を100
とするに必要な水とから構成される脂肪乳剤が挙げられ
る。更に、本発明の脂肪乳剤には、滅菌時及び保存時の
pH低下や着色を防止するために、pH緩衝剤や着色防
止剤を添加してもよい。pH緩衝剤としては、例えば、
L−ヒスチジン、トリス(ヒドロキシメチル)アミノメ
タン等が、着色防止剤としては、例えば、チオグリセロ
ール、ジチオスレイトール等が例示される。これらのp
H緩衝剤及び着色防止剤の添加量は、通常、それぞれ1%
程度以下とされる。更に、ビタミン類(例えば、ビタミ
ンA、ビタミンB類、ビタミンC、ビタミンD類、ビタ
ミンE類、ビタミンK類等)などを添加してもよい。こ
れらの各種添加剤は、粗乳化液に添加してもよく、また
乳化後の脂肪乳剤に添加してもよい。本発明の脂肪乳剤
の液性としては、通常、pH5.0〜8.0程度、好ましくは
5.5〜7.0程度に調整される。The fat emulsion of the present invention thus obtained may be in any suitable form as desired, such as by diluting with water or adjusting the sugar concentration by adding saccharides. As the above saccharides, various saccharides can be used as long as they are saccharides used for infusion, and examples thereof include glucose, fructose, maltose, sorbitol, xylitol, and glycerin. Preferable examples of the composition of the fat emulsion in which the concentration of the saccharide is adjusted are fats and oils 0.1 to 30%, preferably 1 to 20%,
More preferably 2-10%, 0.01-5.0% of emulsifier, preferably
0.05-3%, more preferably 0.1-1%, glucose, fructose,
Maltose, sorbitol, xylitol and one or more saccharides selected from glycerin 5 to 60%, preferably 10 to 40%, more preferably 15 to 30%, and the total amount is 100
And a fat emulsion composed of water necessary for the above. Further, a pH buffering agent or a coloring inhibitor may be added to the fat emulsion of the present invention in order to prevent pH reduction and coloring during sterilization and storage. Examples of the pH buffer include, for example,
L-histidine, tris (hydroxymethyl) aminomethane and the like, and examples of the coloring inhibitor include thioglycerol and dithiothreitol. These p
The addition amounts of the H buffer and the coloring inhibitor are usually 1% each.
Degree or less. Further, vitamins (for example, vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, vitamin K, etc.) may be added. These various additives may be added to the coarse emulsion or may be added to the emulsified fat emulsion. As the liquid properties of the fat emulsion of the present invention, the pH is usually about 5.0 to 8.0, preferably
Adjusted to about 5.5-7.0.
【0010】本発明の脂肪乳剤及び本発明の製造法で得
られた脂肪乳剤は加熱滅菌することができ、加熱滅菌
は、例えば、当該輸液をガラス容器やプラスチック(例
えば、ポリプロピレン、ポリエチレン、エチレン−酢酸
ビニル共重合体、ポリ塩化ビニル等)容器(例えば、バ
ッグ、ボトル等)に充填し、次いで不活性ガス(例え
ば、窒素ガス、ヘリウムガス等)で置換し、密封した
後、滅菌工程に付すことにより行われる。滅菌工程は常
法に準じて行なうことができ、例えば、高圧蒸気滅菌、
熱水浸漬滅菌、熱水シャワー滅菌等の方法により行なう
ことができる。なお、プラスチック容器を用いる場合に
は、実質的に酸素を含まない雰囲気下で滅菌するのが好
ましい。[0010] The fat emulsion of the present invention and the fat emulsion obtained by the production method of the present invention can be heat-sterilized. For example, the heat-sterilization is performed by injecting the infusion solution into a glass container or plastic (for example, polypropylene, polyethylene, ethylene-ethylene glycol). Filling a container (eg, bag, bottle, etc.) with a vinyl acetate copolymer, polyvinyl chloride, etc., then replacing with an inert gas (eg, nitrogen gas, helium gas, etc.), sealing, and then subjecting it to a sterilization step This is done by: The sterilization step can be performed according to a conventional method, for example, high-pressure steam sterilization,
It can be performed by a method such as hot water immersion sterilization and hot water shower sterilization. When a plastic container is used, sterilization is preferably performed in an atmosphere substantially free of oxygen.
【0011】本発明の脂肪乳剤及び本発明の製造法で得
られた脂肪乳剤は栄養補給を目的として生体に投与する
ことができ、そのままで若しくは水で希釈して、又単独
で若しくは必要に応じて他のアミノ酸輸液、電解質輸液
等と混合されて患者に経静脈投与される。更に経口、経
腸等の投与形態での投与にも用いることができる。The fat emulsion of the present invention and the fat emulsion obtained by the production method of the present invention can be administered to a living body for the purpose of nutritional supplementation, and can be used as such or diluted with water. The mixture is mixed with other amino acid infusions, electrolyte infusions and the like, and administered intravenously to patients. Furthermore, it can be used for administration in oral or enteral administration forms.
【0012】[0012]
【実施例】以下、実施例に基づいて本発明をより詳細に
説明するが、本発明はこれらの実施例に限定されるもの
ではない。 実施例1 大豆油及び卵黄リン脂質を含む分散液に、グリセリン又
は各種糖(ブドウ糖、ソルビトール、キシリトール又は
果糖)を添加し粗乳化した後、マントンゴーリンホモジ
ナイザー(ゴーリン社製、15M-8TA型)により乳化(圧
力:550Kg/cm2、液温:70℃以下)して、下記表1に示さ
れる組成の脂肪乳剤を調製した。この際、乳化中におけ
る乳剤の平均粒子径を経時的に測定した。なお、平均粒
子径の測定は、乳剤0.1mlに水100mlを加えて試料溶液と
し、この試料溶液についてマルバーンオートサイザー2C
(マルバーン社製)を用いて行った。また、対照とし
て、グリセリン及び糖類の代りに同量の水を用いて同様
の試験を行った。その結果を図1に示す。なお、図1
中、●はグリセリン、◆はブドウ糖、○はソルビトー
ル、□はキシリトール、▽は果糖、△は対照をそれぞれ
示す。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples. Example 1 Glycerin or various sugars (glucose, sorbitol, xylitol or fructose) were added to a dispersion containing soybean oil and egg yolk phospholipids, coarsely emulsified, and then subjected to manton-gorin homogenizer (manufactured by Gorin, Model 15M-8TA). Emulsification (pressure: 550 kg / cm 2 , liquid temperature: 70 ° C. or lower) was performed to prepare a fat emulsion having the composition shown in Table 1 below. At this time, the average particle size of the emulsion during emulsification was measured with time. The average particle size was measured by adding 100 ml of water to 0.1 ml of the emulsion to prepare a sample solution.
(Manufactured by Malvern). As a control, a similar test was performed using the same amount of water instead of glycerin and saccharides. The result is shown in FIG. FIG.
In the graph, ● represents glycerin, Δ represents glucose, ○ represents sorbitol, □ represents xylitol, Δ represents fructose, and Δ represents control.
【0013】 [0013]
【0014】図1に示されるように、対照系(グリセリ
ン及び糖類を含まない系)においては、乳化機通過回数
が30回になっても平均粒子径は0.2μm程度であった。
また、ソルビトール、キシリトール及び果糖をそれぞれ
含む系においても、乳化機通過回数30回における平均
粒子径は0.18〜0.2μm程度であった。それに対して、グ
リセリン及びブドウ糖を含む系においては、乳化機通過
回数に応じて平均粒子径が急速に低下しており、グリセ
リンを含む系においては乳化機通過回数約8回で、ブド
ウ糖を含む系においては乳化機通過回数約20回で平均
粒子径が0.17μm以下となった。このことから、グリセ
リン及びブドウ糖は、粒子径を低下させる特異的な作用
を有することが明らかとなった。As shown in FIG. 1, in the control system (system containing no glycerin and saccharide), the average particle diameter was about 0.2 μm even when the number of times of passing through the emulsifier was 30.
Also, in the system containing sorbitol, xylitol and fructose respectively, the average particle diameter at the time of passing 30 times of the emulsifier was about 0.18 to 0.2 μm. On the other hand, in the system containing glycerin and glucose, the average particle size is rapidly reduced in accordance with the number of times of passing through the emulsifier, and in the system containing glycerin, the number of times of passing through the emulsifier is about 8 times, In the above, the average particle diameter was 0.17 μm or less after passing through the emulsifier about 20 times. From this, it became clear that glycerin and glucose have a specific action of reducing the particle size.
【0015】実施例2 大豆油60g、卵黄リン脂質7.2g及びブドウ糖500gを水に
加え粗乳化した後、水で全量を1000mlとした。得られた
粗乳化液を、マントンゴーリンホモジナイザー(ゴーリ
ン社製、15M-8TA型)により平均粒子径が0.15μm以下と
なるまで乳化して脂肪乳剤を調製した。この脂肪乳剤50
0mlに水500mlを加えた。得られた脂肪乳剤の組成を表2
に示す。この製剤を50mlのガラス容器に分注し、窒素ガ
スで置換した後、施栓し、次いで115℃、30分間の高圧
蒸気滅菌を施した。滅菌前後の性状、pH及び乳剤の平
均粒子径を比較した。その結果を表3に示す。Example 2 60 g of soybean oil, 7.2 g of egg yolk phospholipid and 500 g of glucose were added to water and coarsely emulsified, and then the total amount was made up to 1000 ml with water. The resulting coarse emulsion was emulsified by a Manton-Gaulin homogenizer (manufactured by Gorin, Model 15M-8TA) until the average particle size became 0.15 μm or less, to prepare a fat emulsion. This fat emulsion 50
500 ml of water was added to 0 ml. Table 2 shows the composition of the obtained fat emulsion.
Shown in This formulation was dispensed into a 50 ml glass container, replaced with nitrogen gas, stoppered, and then subjected to high-pressure steam sterilization at 115 ° C. for 30 minutes. The properties, pH and average particle size of the emulsion before and after sterilization were compared. Table 3 shows the results.
【0016】 [0016]
【0017】 [0017]
【0018】表3に示されるように、滅菌によりpHは
わずかに低下したが、製剤は安定であった。As shown in Table 3, sterilization lowered the pH slightly, but the formulation was stable.
【0019】実施例3 大豆油42.64g及び卵黄リン脂質6.14gを70℃に加温し、7
0%ブドウ糖液429ml(70℃)を加えた後、水にて全量を500
mlに調整し、粗乳化した。次いでマントンゴーリンホモ
ジナイザー(ゴーリン社製、15M-8TA型)を用いて乳化し
(圧力:550Kg/cm2、液温:70℃以下)、平均粒子径が0.1
7μm以下の脂肪乳剤を得た。Example 3 42.64 g of soybean oil and 6.14 g of egg yolk phospholipid were heated to 70 ° C.
After adding 429 ml of 0% glucose solution (70 ° C), the total amount is 500 with water.
It was adjusted to ml and coarsely emulsified. Next, the mixture was emulsified using a Manton-Gaulin homogenizer (manufactured by Gorin, Model 15M-8TA) (pressure: 550 kg / cm 2 , liquid temperature: 70 ° C. or less), and the average particle diameter was 0.1%.
A fat emulsion of 7 μm or less was obtained.
【0020】実施例4 実施例3で得られた脂肪乳剤150mlに注射用水を加えて
全量を500mlとした後、50mlのガラス容器に分注し、窒
素ガスで置換した後、施栓し、次いで115℃、30分間の
高圧蒸気滅菌を施した。かくして得られた製剤は、良好
な乳化状態を長期間維持することができた。Example 4 Water for injection was added to 150 ml of the fat emulsion obtained in Example 3 to make a total volume of 500 ml, dispensed into a 50 ml glass container, replaced with nitrogen gas, plugged, and then sealed. The autoclave was subjected to high-pressure steam sterilization at 30 ° C. for 30 minutes. The formulation thus obtained was able to maintain a good emulsified state for a long period of time.
【0021】実施例5 実施例3で得られた脂肪乳剤200mlに注射用水304ml及び
70%ブドウ糖液13.2mlを加えた後、50mlのガラス容器に
分注し、窒素ガスで置換した後、施栓し、次いで115
℃、30分間の高圧蒸気滅菌を施した。かくして得られた
製剤は、良好な乳化状態を長期間維持することができ
た。Example 5 200 ml of the fat emulsion obtained in Example 3 was mixed with 304 ml of water for injection and
After adding 13.2 ml of 70% glucose solution, the mixture was dispensed into a 50 ml glass container, replaced with nitrogen gas, plugged, and then sealed.
The autoclave was subjected to high-pressure steam sterilization at 30 ° C. for 30 minutes. The formulation thus obtained was able to maintain a good emulsified state for a long period of time.
【0022】[0022]
【発明の効果】以上のように、本発明の脂肪乳剤は平均
粒子径が0.17μm以下に調整されており、脂肪乳剤の滅
菌時及び保存時の安定性の著しい向上が図れると共に他
の輸液剤と混合した際においても良好な乳化状態を長期
間保持することができる。また、本発明の製造法によれ
ば、多量の乳化剤を使用しなくとも、上記の特性を有す
る脂肪乳剤を簡便且つ確実に調製することができる。従
って、本発明によれば、長期にわたり安定性及び安全性
に優れた脂肪乳剤を提供でき、特に、脂肪乳剤に糖類を
配合した輸液製剤においては、比重の相違による相分離
を抑制でき、しかも使用時に脂肪乳剤と糖類とを配合す
る操作を必要としないので、操作が簡便化されると共に
混合時の菌汚染を防止できるという効果を奏する。As described above, the fat emulsion of the present invention is adjusted to have an average particle size of 0.17 μm or less, so that the stability of the fat emulsion during sterilization and storage can be remarkably improved, and at the same time, other infusion agents can be used. , A good emulsified state can be maintained for a long period of time. Further, according to the production method of the present invention, a fat emulsion having the above characteristics can be easily and reliably prepared without using a large amount of an emulsifier. Therefore, according to the present invention, it is possible to provide a fat emulsion excellent in stability and safety over a long period of time. Particularly, in an infusion preparation in which a saccharide is blended with a fat emulsion, phase separation due to a difference in specific gravity can be suppressed, and furthermore, it can be used. In some cases, an operation of blending the fat emulsion and the saccharide is not required, so that the operation is simplified, and there is an effect that bacterial contamination during mixing can be prevented.
図1は、実施例1の脂肪乳剤の調製において、乳化機通
過回数と脂肪乳剤の平均粒子径との関係を示す図であ
る。同図中、●はグリセリン、◆はブドウ糖、○はソル
ビトール、□はキシリトール、▽は果糖、△は対照をそ
れぞれ示す。FIG. 1 is a diagram showing the relationship between the number of times of passage through an emulsifier and the average particle size of a fat emulsion in the preparation of a fat emulsion of Example 1. In the figure, ● represents glycerin, Δ represents glucose, ○ represents sorbitol, □ represents xylitol, Δ represents fructose, and Δ represents control.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 31/045 A61K 31/045 31/23 31/23 31/70 ADD 31/70 ADD 47/06 47/06 H (72)発明者 村島 良一郎 枚方市招提大谷二丁目25番1号 株式会 社ミドリ十字 中央研究所内 (72)発明者 阿部 俊一 枚方市招提大谷二丁目25番1号 株式会 社ミドリ十字 中央研究所内 (72)発明者 横山 和正 枚方市招提大谷二丁目25番1号 株式会 社ミドリ十字 中央研究所内 (56)参考文献 特開 平2−167217(JP,A) 特開 昭55−147228(JP,A) 特開 昭62−29511(JP,A) 特開 平3−161430(JP,A) (58)調査した分野(Int.Cl.6,DB名) A61K 9/107 A61K 47/06 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 31/045 A61K 31/045 31/23 31/23 31/70 ADD 31/70 ADD 47/06 47/06 H (72) Inventor Ryoichiro Murashima 2- 25-1, Odani Otani, Hirakata City, Japan Midori Cross Central Research Laboratories (72) Inventor Shunichi Abe 2-25-1, Odani Otani, Hirakata City Midori Cross Central Research Institute (72) Inventor Kazumasa Yokoyama 2-5-1 Otani Otani, Hirakata City Midori Cross Central Research Institute, Inc. (56) References JP-A-2-167217 (JP, A) JP-A-55-147228 (JP, A) 62-29511 (JP, A) JP-A-3-161430 (JP, A) (58) Fields investigated (Int. Cl. 6 , DB name) A61K 9/107 A61K 47/06
Claims (5)
養補給用脂肪乳剤であって、油脂0.1〜30W/V
%、リン脂質0.01〜5W/V%、ブドウ糖30〜7
0W/V%を含有し、脂肪乳剤の平均粒子径が0.17
μm以下であることを特徴とする脂肪乳剤。Claims: 1. A fat emulsion for nutritional supplement wherein an oil or fat is emulsified using an emulsifier, wherein the oil or fat is 0.1 to 30 W / V.
%, Phospholipid 0.01-5W / V%, glucose 30-7
0 W / V%, and the fat emulsion has an average particle size of 0.17
a fat emulsion having a particle size of not more than μm.
養補給用脂肪乳剤であって、油脂0.1〜30W/V
%、リン脂質0.01〜5W/V%、ブドウ糖、果糖、
マルトース、ソルビトール及びキシリトールから選ばれ
た1種又は2種以上5〜60W/V%を含有し、脂肪乳
剤の平均粒子径が0.17μm以下であることを特徴と
する脂肪乳剤。 2. An emulsion obtained by emulsifying a fat or oil with an emulsifier.
A fat emulsion for nutritional supplementation, comprising 0.1 to 30 W / V of fats and oils.
%, Phospholipid 0.01-5W / V%, glucose, fructose,
Selected from maltose, sorbitol and xylitol
Fat milk containing 5 to 60 W / V%
Characterized in that the average particle size of the agent is 0.17 μm or less
Fat emulsion.
リグリセリド及び化学合成トリグリセリドから選ばれた
1種又は2種以上であり、リン脂質が卵黄リン脂質、水
素添加卵黄リン脂質、大豆リン脂質及び水素添加大豆リ
ン脂質から選ばれた1種又は2種以上である請求項1又
は2のいずれかに記載の脂肪乳剤。 3. The method according to claim 1, wherein the fat or oil is a vegetable oil, a fish oil, or a medium-chain fatty acid.
Selected from glycerides and chemically synthesized triglycerides
One or two or more phospholipids such as egg yolk phospholipids, water
Egg yolk phospholipids, soybean phospholipids and hydrogenated soybean liquor
One or more selected from phospholipids.
Is the fat emulsion according to any of 2.
を用いて乳化し、平均粒子径が0.17μm以下の脂肪
乳剤を得ることを特徴とする栄養補給用脂肪乳剤の製造
法。 4. A fat and / or oil, together with glucose, a phospholipid.
Emulsified using a fat having an average particle size of 0.17 μm or less
Production of a fat emulsion for nutritional supplements characterized by obtaining an emulsion
Law.
セリド及び化学合成トリグリセリドから選ばれた1種又
は2種以上の油脂を、ブドウ糖とともに、卵黄リン脂
質、水素添加卵黄リン脂質、大豆リン脂質及び水素添加
大豆リン脂質から選ばれた1種又は2種以上のリン脂質
を用いて乳化させる請求項4記載の栄養補給用脂肪乳剤
の製造法。 5. Vegetable oil, fish oil, medium chain fatty acid triglyceride
One or more selected from cerides and chemically synthesized triglycerides
Is a mixture of two or more fats and oils, together with glucose,
Quality, hydrogenated egg yolk phospholipids, soybean phospholipids and hydrogenated
One or more phospholipids selected from soybean phospholipids
5. The fat emulsion for nutritional supplement according to claim 4, wherein the fat emulsion is emulsified by using.
Manufacturing method.
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3222031A JP2950348B2 (en) | 1991-04-27 | 1991-08-06 | Fat emulsion and method for producing the same |
DK95104553T DK0671166T3 (en) | 1991-04-26 | 1992-04-24 | Nutritional Preparations |
DE69232811T DE69232811T2 (en) | 1991-04-26 | 1992-04-24 | Infustionspräparat |
EP92107054A EP0510687B1 (en) | 1991-04-26 | 1992-04-24 | Infusion preparation |
DE69232957T DE69232957T2 (en) | 1991-04-26 | 1992-04-24 | Containers filled with liquid infusions |
DK96115944T DK0752243T3 (en) | 1991-04-26 | 1992-04-24 | Container filled with infusion solutions |
ES96115944T ES2188704T3 (en) | 1991-04-26 | 1992-04-24 | CONTAINER FILLING WITH INFUSION LIQUIDS. |
EP95104553A EP0671166B1 (en) | 1991-04-26 | 1992-04-24 | Nutrient-supplying infusion |
EP96115944A EP0752243B1 (en) | 1991-04-26 | 1992-04-24 | Container filled with infusion liquids |
DE69233437T DE69233437T2 (en) | 1991-04-26 | 1992-04-24 | Infusion for delivery of food |
CA002067062A CA2067062C (en) | 1991-04-26 | 1992-04-24 | Infusion preparation |
DK92107054T DK0510687T3 (en) | 1991-04-26 | 1992-04-24 | infusion |
ES92107054T ES2181669T3 (en) | 1991-04-26 | 1992-04-24 | INFUSION PREPARATION. |
TW081103293A TW320563B (en) | 1991-04-26 | 1992-04-25 | |
KR1019920007018A KR920019370A (en) | 1991-04-26 | 1992-04-25 | Infusion preparations |
US08/478,970 US5674527A (en) | 1991-04-26 | 1995-06-07 | Infusion preparation comprising phospholipid |
US08/475,812 US5972367A (en) | 1991-04-26 | 1995-06-07 | Infusion preparation |
US08/589,207 US5626880A (en) | 1991-04-26 | 1996-01-22 | Infusion preparation |
US09/244,931 US6475506B1 (en) | 1991-04-26 | 1999-02-10 | Infusion preparation |
KR1019990023090A KR100244997B1 (en) | 1991-04-26 | 1999-06-19 | A container filled with infusion liquids |
KR1019990062610A KR100489158B1 (en) | 1991-04-26 | 1999-12-27 | Intravenous injection preparation |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12486391 | 1991-04-27 | ||
JP3-124863 | 1991-04-27 | ||
JP3222031A JP2950348B2 (en) | 1991-04-27 | 1991-08-06 | Fat emulsion and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH059111A JPH059111A (en) | 1993-01-19 |
JP2950348B2 true JP2950348B2 (en) | 1999-09-20 |
Family
ID=26461431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3222031A Expired - Fee Related JP2950348B2 (en) | 1991-04-26 | 1991-08-06 | Fat emulsion and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2950348B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06312923A (en) * | 1993-04-30 | 1994-11-08 | Green Cross Corp:The | Nutritional infusion for peripheral intravenous administration |
CN102811717A (en) * | 2010-03-26 | 2012-12-05 | 味之素株式会社 | Nutritional composition |
US8318233B2 (en) * | 2010-03-26 | 2012-11-27 | Corn Products Development Inc | Emulsions useful in beverages |
-
1991
- 1991-08-06 JP JP3222031A patent/JP2950348B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH059111A (en) | 1993-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Collins-Gold et al. | Parenteral emulsions for drug delivery | |
US6528067B1 (en) | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof | |
AU2007305614B2 (en) | O/W/O emulsion containing lignan compounds and composition containing the same | |
KR860001774B1 (en) | Manufacturing method of oil-in-water emulsion for nutrition | |
TWI321989B (en) | Water-soluble composition containing coenzyme q10 | |
JPWO2011118810A1 (en) | Nutritional composition | |
DE69232811T2 (en) | Infustionspräparat | |
CN103006751B (en) | Medium and long chain fat emulsion injection and preparation method thereof | |
WO2010127541A1 (en) | A nano-emulsion injection of vinca alkaloids and the preparation method thereof | |
US4970209A (en) | Fat emulsions | |
JP2004196781A (en) | Water-soluble composition containing coenzyme Q10 | |
JP2950348B2 (en) | Fat emulsion and method for producing the same | |
US5760020A (en) | Lipid emulsion | |
JPS58162517A (en) | Fat emulsion containing fat-soluble vitamins | |
JP3109161B2 (en) | Infusion preparation | |
JP3132085B2 (en) | Fat emulsion | |
JP3446035B2 (en) | Infusion preparation | |
JPH0213643B2 (en) | ||
JP2940249B2 (en) | Infusion preparation | |
JP3097196B2 (en) | Stabilization of fat emulsion | |
EP0313617B1 (en) | Lipid emulsion and method for intravenous infusion | |
JPH02273619A (en) | Aqueous solution containing oil-soluble medicine | |
JP3364932B2 (en) | Infusion container | |
JP3236373B2 (en) | Liquid enteral nutrition in the form of a kit composed of multiple liquids | |
JPH0532540A (en) | Infusion formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080709 Year of fee payment: 9 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080709 Year of fee payment: 9 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080709 Year of fee payment: 9 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |